🌿 Environment 8h ago · Jonathan Gardner

Merck KGaA bets on RNAi with $1.3B Silence buyout

BioPharma Dive
BioPharma industry news
View Channel →
Merck KGaA bets on RNAi with $1.3B Silence buyout
Source ↗ 👁 0 💬 0
The acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.

Comments (0)

Sign in to join the discussion

More Like This

Cutting air pollution and greenhouse gases could save Africa billions while improving health
Earth News - Earth Science News, Earth Science, Climate Change · 4h ago
Social norms and infrastructure could help climate transitions stick
Earth News - Earth Science News, Earth Science, Climate Change · 4h ago
Pennsylvania study aims to identify power plant sites that can be reactivated
EHN · 4h ago
Many data centers are located where water resources are limited
Earth News - Earth Science News, Earth Science, Climate Change · 4h ago
Webinar – Building an integrated geothermal heating system in Oostland region, 23 October 2026
ThinkGeoEnergy – Geothermal News & Insights · 4h ago
Endurance Energy demonstrates subsea geothermal power in Pacific Ocean
ThinkGeoEnergy – Geothermal News & Insights · 4h ago